Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews

Vaccine

Volumn 27, Issue 40, 2009, Pages 5505-5512

  Leask, Julie ^a,b   Jackson, Cath ^c   Trevena, Lyndal ^b   McCaffery, Kirsten ^b   Brotherton, Julia ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Evaluation; HPV vaccination; Qualitative

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; CANCER IMMUNIZATION; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION;

AUSTRALIA; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 68349155684     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.102     Document Type: Article

References (32)

1. Department of Immunization, Vaccines and Biologicals, Expanded Programme on Immunization. WHO vaccine-preventable diseases: monitoring system. 2007 global summary. (WHO/IVB/2007). Geneva: World Health Organization; 2007.
2. Brotherton J., Wang H., Schaffer A., Quinn H., Menzies R., Hull B., et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Commun Dis Intell 31 Suppl. (2007) viii-S152
3. Smith M., Canfell K., Brotherton J., Lew J.-B., Barnabas R., and on behalf of the Modellers Sans Frontières working group. The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer 123 (2008) 1854-1863
4. Zhou J., Sun X.Y., Stenzel D.J., and Frazer I.H. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185 (1997) 251-257
5. Rambout L., Hopkins L., Hutton B., and Fergusson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ (2007) 177
6. World Health Organization. Global Advisory Committee on Vaccine Safety, 12-13 June 2007. Safety of human papillomavirus vaccine. Wkly Epidemiol Rec 2007;82:252-9.
7. Government funds Gardasil (media release). 29-11-2006. Available at: (accessed 23.05.08).
8. Department of Health (UK). HPV vaccine recommended for NHS immunisation programme. 26-10-2007. Available at: (accessed 15.07.08).
9. Lippman A., Boscoe M., and Scurfield C. Rebuttal: do you approve of spending $300 million on HPV vaccination? No. Can Fam Physician 54 343 (2008) 345
10. Steben M. Rebuttal: do you approve of spending $300 million on HPV vaccination? Yes. Can Fam Physician 54 342 (2008) 344
11. Wright Jr. T.C., Huh W.K., Monk B.J., Smith J.S., Ault K.A., and Herzog T.J. Age considerations when vaccinating against HPV. Gynecol Oncol 109 2 Suppl. (2008) S40-S47
12. Michie S., Johnston M., Abraham C., Lawton R., Parker D., and Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care 14 (2005) 26-33
13. Michie S., Pilling S., Garety P., Whitty P., Eccles M.P., Johnston M., et al. Difficulties implementing a mental health guideline: an exploratory investigation using psychological theory. Implement Sci 2 (2007) 8
14. Michie S., Hendy J., Smith J., and Adshead F. Evidence into practice: a theory based study of achieving national health targets in primary care. J Eval Clin Pract 10 (2004) 447-456
15. Ritchie J., and Spencer L. Qualitative data analysis for applied policy research. In: Bryman A., and Burgess R.G. (Eds). Analyzing qualitative data (1994), Routledge, London
16. Clements C.J. Gardasil and mass psychogenic illness [letter]. Aust N Z J Public Health 31 (2007) 387
17. Roughead E.E., Gilbert A.L., and Vitry A.I. The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy. Health Policy 88 (2008) 250-257
18. Weisberg E., Bateson D., McCaffery K., and Skinner S.R. HPV vaccination catch up program. Utilisation by young Australian women. Aust Fam Physician 38 (2009) 72-76
19. Brotherton JML, Mullins R. Estimating coverage of the National HPV Vaccination Program: where are we at? Med J Aust;191(3):188.
20. Cutts F.T., Glik D.C., Gordon A., Parker K., Diallo S., Haba F., et al. Application of multiple methods to study the immunization programme in an urban area of Guinea. Bull World Health Organ 68 (1990) 769-776
21. de la Hoz F., Perez L., Wheeler J.G., de Neira M., and Hall A.J. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?. Trop Med Int Health 10 (2005) 322-329
22. de Timóteo Mavimbe J.C., Muquingue H.N., Braa J., and Bjune G. Immunization coverage in Mozambique: from concepts to decision-making. Health Policy 79 (2006) 92-100
23. Berhanel Y., Bekele A., Tesfaye F., and Immunization. (EPI) in Ethiopia: acceptance, coverage, and sustainability. Ethiop Med J 38 Suppl. 1 (2000) 1-60
24. Mangrio N.K., Alam M.M., and Shaikh B.T. Is Expanded Programme on Immunization doing enough? Viewpoint of health workers and managers in Sindh, Pakistan. J Pak Med Assoc 58 (2008) 64-67
25. Russell G., Sutton J., Reid G.J., Beynon C., Cohen I., and Huffman D. Universal influenza immunization. Were Ontario family physicians prepared?. Can Fam Physician 49 (2003) 1315-1321
26. Tissot A.M., Zimet G.D., Rosenthal S.L., Bernstein D.I., Wetzel C., and Kahn J.A. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health 41 (2007) 119-125
27. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 18 (2005) 391-398
28. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 37 (2005) 502-510
29. Raley J.C., Followwill K.A., Zimet G.D., and Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 12 (2004) 127-133
30. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 25 (2007) 7841-7847
31. Brewer N.T., and Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45 (2007) 107-114
32. Leask J. Vaccination and risk communication: summary of a workshop, Arlington Virginia, USA, 5-6 October 2000. J Paediatr Child Health 38 (2002) 124-128